Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats. (Q44588999)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680083%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680083%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680083%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Antonio P Carobrez

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680083%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Leandro J Bertoglio

series ordinal

1

1 reference

4 December 2017

Antonio P Carobrez

series ordinal

2

1 reference

4 December 2017

publication date

10 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680083%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

number of pages

8

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680083%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680083%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680083%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

335-342

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680083%20AND%20SRC:MED&resulttype=core&format=json

One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure.

16 December 2019

cites work

1 reference

12 December 2020

Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze

1 reference

12 December 2020

Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice

1 reference

12 December 2020

The glutamate receptor ion channels

1 reference

12 December 2020

"One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?

1 reference

12 December 2020

A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus.

1 reference

12 December 2020

Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents

1 reference

12 December 2020

Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1.

1 reference

12 December 2020

A conflict procedure not requiring deprivation: evidence that chronic ethanol treatment induces tolerance to the anticonflict action of ethanol and chlordiazepoxide

1 reference

12 December 2020

Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze.

1 reference

12 December 2020

Differential anxiolytic efficacy of a benzodiazepine on first versus second exposure to a predatory odor in rats.

1 reference

12 December 2020

Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain

1 reference

12 December 2020

Effects of glycine or (+/-)-3-amino-1-hydroxy-2-pyrrolidone microinjections along the rostrocaudal axis of the dorsal periaqueductal gray matter on rats' performance in the elevated plus-maze task

1 reference

12 December 2020

Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety.

1 reference

12 December 2020

Modulation of defensive behavior by periaqueductal gray NMDA/glycine-B receptor

1 reference

12 December 2020

Influence of prior experience on mice behavior using the four-plate test.

1 reference

12 December 2020

Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?

1 reference

12 December 2020

The use of a plus-maze to measure anxiety in the mouse

1 reference

12 December 2020

Trial 2 in the elevated plus-maze: a different form of fear?

1 reference

12 December 2020

One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat.

1 reference

12 December 2020

One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure.

1 reference

12 December 2020

An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs

1 reference

12 December 2020

Ethanol tolerance and synaptic plasticity

1 reference

12 December 2020

Anatomy and physiology of glutamate in the CNS.

1 reference

12 December 2020

Effects of ethanol, MK-801, and chlordiazepoxide on locomotor activity in different rat lines: dissociation of locomotor stimulation from ethanol preference.

1 reference

12 December 2020

Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans

1 reference

12 December 2020

Anxiolytic activity of glycine-B antagonists and partial agonists--no relation to intrinsic activity in the patch clamp.

1 reference

12 December 2020

Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze

1 reference

12 December 2020

Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience

1 reference

12 December 2020

Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal/nocturnal phases and under different illumination conditions.

1 reference

12 December 2020

Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey

1 reference

12 December 2020

The influence of open arm ledges and maze experience in the elevated plus-maze

1 reference

12 December 2020

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice

1 reference

12 December 2020

Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze.

1 reference

12 December 2020

The interplay of learning and anxiety in the elevated plus-maze

1 reference

12 December 2020

Immediate increase in benzodiazepine binding in rat brain after a single brief experience in the plus maze: a paradoxical effect.

1 reference

12 December 2020

Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test

1 reference

12 December 2020

The phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation.

1 reference

12 December 2020

Effects of intra-hippocampal infusion of WAY-100635 on plus-maze behavior in mice. Influence of site of injection and prior test experience

1 reference

12 December 2020

GABAergic and glutamatergic modulation of exploratory behavior in the dorsomedial hypothalamus

1 reference

12 December 2020

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes

1 reference

12 December 2020

Oxiracetam prevents the MK-801 induced amnesia for the elevated plus-maze in mice.

1 reference

12 December 2020